Hester Biosciences Ltd
Hester Biosciences Ltd is one of the leading animal health care companies & the second largest poultry vaccine manufacturer in India. Founded by Mr. Rajiv Gandhi in 1987, it has now a presence in over 30 countries & has a key market in India, Nepal & Tanzania
Partners with Bill & Melinda Gates Foundation, GALVmed, Golchha Organisation, Novapharma, etc.
Also, provides services like seroprofiling kits and diagnostic labs for poultry flocks, and mastitis control programs for cattle.#
Revenue Mix:
India - 84%, Nepal - 8%, Africa 1.5%.
- Market Cap ₹ 1,407 Cr.
- Current Price ₹ 1,654
- High / Low ₹ 1,900 / 864
- Stock P/E 51.2
- Book Value ₹ 245
- Dividend Yield 0.40 %
- ROCE 16.3 %
- ROE 15.2 %
- Face Value ₹ 10.0
Pros
- Company has been maintaining a healthy dividend payout of 25.00%
Cons
- Company might be capitalizing the interest cost
- Debtor days have increased from 90.15 to 116.39 days.
Peer comparison
Sector: Pharmaceuticals Industry: Pharmaceuticals - Indian - Formulations
Quarterly Results
Consolidated Figures in Rs. Crores / View Standalone
Jun 2018 | Sep 2018 | Dec 2018 | Mar 2019 | Jun 2019 | Sep 2019 | Dec 2019 | Mar 2020 | Jun 2020 | Sep 2020 | Dec 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
40 | 43 | 46 | 52 | 45 | 44 | 51 | 44 | 40 | 53 | 57 | |
25 | 27 | 26 | 35 | 27 | 33 | 30 | 36 | 28 | 38 | 36 | |
Operating Profit | 15 | 15 | 20 | 17 | 18 | 11 | 21 | 7 | 12 | 16 | 21 |
OPM % | 37% | 36% | 44% | 33% | 39% | 25% | 41% | 16% | 30% | 30% | 37% |
Other Income | 1 | 0 | 0 | 6 | 1 | 1 | 0 | 5 | 1 | 0 | 1 |
Interest | 1 | 2 | 1 | 2 | 2 | 1 | 3 | 3 | 2 | 2 | 2 |
Depreciation | 2 | 3 | 3 | 4 | 3 | 3 | 3 | 3 | 3 | 3 | 3 |
Profit before tax | 12 | 10 | 17 | 17 | 13 | 7 | 15 | 6 | 8 | 11 | 18 |
Tax % | 31% | 44% | 26% | 20% | 38% | 13% | 20% | 24% | 36% | 37% | 27% |
Net Profit | 9 | 7 | 13 | 10 | 8 | 7 | 12 | 3 | 6 | 7 | 12 |
EPS in Rs | 10.14 | 8.19 | 15.05 | 11.52 | 9.86 | 7.66 | 13.54 | 3.22 | 6.72 | 7.85 | 14.52 |
Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes | Notes |
Profit & Loss
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | TTM | |
---|---|---|---|---|---|---|---|---|---|---|---|
42 | 48 | 65 | 69 | 90 | 101 | 123 | 136 | 178 | 183 | 194 | |
24 | 30 | 43 | 44 | 64 | 67 | 82 | 89 | 110 | 127 | 138 | |
Operating Profit | 18 | 19 | 22 | 24 | 25 | 34 | 41 | 47 | 68 | 56 | 56 |
OPM % | 43% | 39% | 34% | 36% | 28% | 34% | 33% | 35% | 38% | 30% | 29% |
Other Income | 0 | 0 | 0 | 1 | 3 | 1 | 0 | 3 | 7 | 6 | 7 |
Interest | 3 | 3 | 3 | 6 | 5 | 4 | 4 | 4 | 7 | 8 | 8 |
Depreciation | 4 | 4 | 4 | 5 | 6 | 6 | 7 | 10 | 12 | 13 | 13 |
Profit before tax | 11 | 12 | 14 | 13 | 18 | 25 | 31 | 36 | 57 | 41 | 42 |
Tax % | 32% | 37% | 37% | 31% | 26% | 23% | 26% | 36% | 28% | 25% | |
Net Profit | 8 | 8 | 9 | 9 | 14 | 19 | 24 | 26 | 42 | 29 | 27 |
EPS in Rs | 8.95 | 10.89 | 11.11 | 15.99 | 22.57 | 27.68 | 30.12 | 48.87 | 34.29 | 32.31 | |
Dividend Payout % | 24% | 7% | 18% | 18% | 19% | 18% | 19% | 33% | 23% | 19% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | 15% |
3 Years: | 14% |
TTM: | 1% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 7% |
TTM: | -24% |
Stock Price CAGR | |
---|---|
10 Years: | 35% |
5 Years: | 31% |
3 Years: | -1% |
1 Year: | 12% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | 20% |
3 Years: | 20% |
Last Year: | 15% |
Balance Sheet
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Sep 2020 | |
---|---|---|---|---|---|---|---|---|---|---|---|
5 | 6 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | 9 | |
Reserves | 41 | 54 | 59 | 66 | 76 | 93 | 113 | 132 | 169 | 193 | 200 |
Borrowings | 21 | 16 | 32 | 48 | 55 | 59 | 66 | 69 | 90 | 126 | 126 |
15 | 19 | 24 | 19 | 20 | 25 | 25 | 35 | 32 | 57 | 99 | |
Total Liabilities | 82 | 95 | 124 | 142 | 160 | 186 | 213 | 244 | 299 | 384 | 434 |
39 | 39 | 38 | 54 | 60 | 65 | 102 | 110 | 145 | 142 | 250 | |
CWIP | 0 | 6 | 29 | 21 | 33 | 36 | 21 | 32 | 7 | 74 | 1 |
Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
43 | 50 | 57 | 68 | 68 | 85 | 89 | 102 | 148 | 168 | 183 | |
Total Assets | 82 | 95 | 124 | 142 | 160 | 186 | 213 | 244 | 299 | 384 | 434 |
Cash Flows
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
5 | 14 | 12 | 9 | 20 | 19 | 35 | 38 | 47 | 38 | |
-4 | -10 | -23 | -15 | -21 | -13 | -30 | -26 | -21 | -74 | |
-1 | -2 | 10 | 7 | 7 | -7 | 2 | -11 | 3 | 19 | |
Net Cash Flow | 1 | 2 | -1 | 2 | 5 | -1 | 6 | 1 | 28 | -18 |
Ratios
Consolidated Figures in Rs. Crores / View Standalone
Mar 2011 | Mar 2012 | Mar 2013 | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | |
---|---|---|---|---|---|---|---|---|---|---|
ROCE % | 20% | 20% | 18% | 15% | 19% | 20% | 20% | 27% | 16% | |
Debtor Days | 115 | 109 | 85 | 75 | 72 | 95 | 79 | 87 | 67 | 116 |
Inventory Turnover | 0.41 | 0.64 | 0.47 | 0.91 | 0.81 | 1.13 | 0.96 | 0.93 | 0.63 |
Documents
Add documentRecent announcements
- Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome 8 Feb
- Shareholder Meeting / Postal Ballot-Notice of Postal Ballot 3 Feb
- Postal Ballot 2 Feb
- Announcement under Regulation 30 (LODR)-Press Release / Media Release 30 Jan
- 20201231 Q3_9M FY21 Results 30 Jan
View all
Annual reports
- Financial Year 2020 from bse
- Financial Year 2019 from bse
- Financial Year 2018 from bse
- Financial Year 2017 from bse
- Financial Year 2016 from bse
- Financial Year 2015 from bse
- Financial Year 2014 from bse
- Financial Year 2013 from bse
- Financial Year 2012 from bse
- Financial Year 2011 from bse
- Financial Year 2010 from bse